Hamed Amini, CEO and co-founder of #Hepta Bio, tells us how his company's #liquidbiopsy can diagnose liver fibrosis due to MASH, identifying patients who are treatment candidates.

🎧 Listen now → www.ontargetpodcast.com

#OnTarget #PrecisionMedicine #MASH #Epigenetics #LiverDisease #Diagnostics #AI